Haemonetics (NYSE: HAE) is seeing sharp upside following third quarter earnings ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Trader Talk

Haemonetics (HAE) Tops Q3 EPS by 2cFebruary 1, 2016 6:03 AM Haemonetics Reports 3rd Quarter Fiscal 2016 Revenue of $233 Million, Constant Currency Revenue Growth of 4% and 1% As ReportedFebruary 1, 2016 6:00 AM